ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 910

$685K Total Retail Price of All Prescriptions

Rank: 76 out of 910

998 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 998 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 998 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,711 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 584 569 1 3
LEVOTHYROXINE SODIUM 582 558 2 1
LISINOPRIL 499 478 3 2
OMEPRAZOLE 281 270 4 5
HYDROCHLOROTHIAZIDE 272 272 5 12
HYDROCODONE-ACETAMINOPHEN 264 258 S3 6 8
GABAPENTIN 231 227 7 13
ZOLPIDEM TARTRATE 229 224 8 17
AMLODIPINE BESYLATE 224 220 9 4
ATENOLOL 222 219 10 10
WARFARIN SODIUM 217 217 11 11
METOPROLOL TARTRATE 199 190 12 7
CRESTOR 194 187 13 26
FLUTICASONE PROPIONATE 190 189 14 23
METFORMIN HCL 182 178 15 6
LOSARTAN POTASSIUM 180 175 16 15
TRIAMTERENE-HCTZ 176 176 17 39
METOPROLOL SUCCINATE 170 162 18 21
ATORVASTATIN CALCIUM 162 156 19 14
CITALOPRAM HBR 156 152 20 19
FINASTERIDE 148 144 21 59
ALENDRONATE SODIUM 140 135 22 22
TAMSULOSIN HCL 138 133 23 29
FUROSEMIDE 129 120 24 9
DIOVAN 123 123 25 34
PREDNISONE 122 117 26 43
LOVASTATIN 119 111 27 20
DOXAZOSIN MESYLATE 113 113 28 62
TRAZODONE HCL 110 97 29 37
ALLOPURINOL 103 102 30 33
AZITHROMYCIN 99 97 31 41
CIPROFLOXACIN HCL 97 95 32 48
PANTOPRAZOLE SODIUM 95 91 33 27
POTASSIUM CHLORIDE 88 86 34 18
CLOPIDOGREL 83 80 35 35
TOPROL XL 82 82 36 237
DONEPEZIL HCL 77 77 37 32
SERTRALINE HCL 76 69 38 24
LORAZEPAM 72 72 39 151
TRAMADOL HCL 72 72 39 25
FLUOXETINE HCL 70 66 41 49
ALPRAZOLAM 70 60 41 172
CALCITONIN-SALMON 68 68 43 200
LIDODERM 60 60 44 164
OXYCODONE-ACETAMINOPHEN 56 43 S2 45 31
TERAZOSIN HCL 55 51 46 61
LANTUS SOLOSTAR 52 49 47 112
CARVEDILOL 52 52 47 36
ESTRADIOL 51 51 R 49 92
CEPHALEXIN 51 49 49 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.